Researchers must comply with all applicable federal, state, local, and institutional regulations and must obtain all necessary approvals prior to any experimental work
GLP-1 receptor agonists work by: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood glucose levels without causing excessive hypoglycaemia Suppressing glucagon release from alpha cells, reducing hepatic glucose production Slowing gastric emptying , which prolongs the feeling of fullness after meals Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger and food intake These medications are administered via subcutaneous injection, typically once weekly or once daily depending on the specific formulation
- Fat Distribution: Assists in even fat distribution across the body, particularly targeting stubborn areas like the abdomen and thighs
It helps calm down excessive inflammation, which can be a game-changer for conditions like arthritis or inflammatory gut issues
Disturbed glucoregulatory response to food intake after moderate sleep restriction
